🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
360 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

60 mcg
✅ Within RDA (0.5× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.06mg

Other Ingredients

Extra Virgin Olive Oil Gelatin Water, Purified Glycerin

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) No Allergies Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use Consume one capsule daily. You can increase your intake as required or as guided by your physician.

🧪 Formulation Notes

Since 1979, Unsurpassed purity, quality and efficacy. 100% solar production Zero carbon footprint 100% solar

Vitamin K's most beneficial form

Promotes optimum heart + bone + circulatory health

Andrew Lessman's Vitamin K2 MK-7 60 provides the most beneficial form of vitamin K in the form of vitamin K2 menaquinone-7 (K2 MK-7). Vitamin K2 MK-7 is now recognized as essential for bone and heart health through its role in regulating calcium metabolism. Unlike typical vitamin K1 and its role in blood clotting, vitamin K2 MK-7 is unique given its essential role in calcium utilization and thus bone, heart and circulatory health. Essentially, K2 MK-7 promotes the retention of calcium in healthy bone while inhibiting undesirable calcification in tissues such as arteries, heart valves, etc. By reducing calcification, K2 MK-7 promotes flexible, resilient arteries and heart valves - a defining characteristic of cardiovascular health. In short, K2 MK-7 help our body retain calcium where required (our bones) and reduce deposits where calcification is to be avoided. Unfortunately, there is no meaningful source of K2 MK-7 in the American diet, so achieving these desirable heart and bone health benefits requires supplementation of this essential vitamin.

Contains no additives or common allergens Contains no milk, soy, yeast, corn, wheat, gluten, sodium, salt, sugar, cholesterol, color, preservative, common allergens, genetically modified (GMO) ingredients or manufacturing additives.

Additional Information

For questions about the use of this product call 800.800.1200. Andrew Lessman, Founder Questions? Reorders? 800.800.1200 www.Procapslabs.com Andrew Lessman

Product Details

UPC / SKU 743387
DSLD Entry Date 2025-05-21
Product Type Vitamin
Form Capsule
Brand ProCaps
DSLD ID 331626
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →